Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SANDOSTATIN LAR for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 45 adverse event reports in the FDA FAERS database where SANDOSTATIN LAR was used for Off label use.

Most Reported Side Effects for SANDOSTATIN LAR

Side Effect Reports % Deaths Hosp.
Death 117 29.3% 117 37
Diarrhoea 49 12.3% 19 24
Malaise 49 12.3% 19 30
Asthenia 45 11.3% 25 32
Malignant neoplasm progression 45 11.3% 30 20
Nausea 37 9.3% 16 26
Weight decreased 37 9.3% 19 26
Fatigue 36 9.0% 19 22
Pain 34 8.5% 10 22
Vomiting 31 7.8% 15 23
Dyspnoea 29 7.3% 15 23
Blood pressure increased 26 6.5% 19 15
Dizziness 24 6.0% 7 15
Abdominal pain 23 5.8% 10 15
Decreased appetite 21 5.3% 10 14

Other Indications for SANDOSTATIN LAR

Acromegaly (86) Neuroendocrine tumour (82) Carcinoid tumour (34) Carcinoid syndrome (31) Pancreatic neuroendocrine tumour (25) Diarrhoea (6) Meningioma (6) Endocrine neoplasm (5) Metastatic carcinoid tumour (5) Neuroendocrine carcinoma (5)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

SANDOSTATIN LAR Full Profile All Off label use Drugs SANDOSTATIN LAR Demographics SANDOSTATIN LAR Timeline